Smoking cessation among Australian methadone clients: Prevalence, characteristics and a need for action

Drug and Alcohol Review

Volumn 31, Issue 4, 2012, Pages 507-513

  Bowman, Jenny ^a,b   Wiggers, John ^a,b,c   Colyvas, Kim ^a   Wye, Paula ^a,b,c   Walsh, Raoul A ^a,b   Bartlem, Kate ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^c Hunter New England Population Health   (Australia)

Author keywords

Methadone; Motivation; Quit attempt; Smoking cessation

Indexed keywords

METHADONE; NARCOTIC AGENT;

ADULT; ARTICLE; AUSTRALIA; CROSS-SECTIONAL STUDY; FEMALE; HEROIN DEPENDENCE; HUMAN; MALE; METHODOLOGY; MOTIVATION; OPIATE SUBSTITUTION TREATMENT; PREVALENCE; SMOKING; SMOKING CESSATION; STATISTICS; TOBACCO DEPENDENCE;

ADULT; AUSTRALIA; CROSS-SECTIONAL STUDIES; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; MOTIVATION; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; PREVALENCE; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 84861894336     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/j.1465-3362.2011.00408.x     Document Type: Article

References (54)

1. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50years' observations on male British doctors. BMJ 2004;328:1519.
2. Mackay J, Eriksen M. The tobacco atlas. Geneva: World Health Organization, 2002.
3. Emery S, Gilpin EA, Ake C, Farkas AJ, Pierce JP. Characterizing and identifying 'hard-core' smokers: implications for further reducing smoking prevalence. Am J Public Health 2000;90:387-94.
4. Piasecki TM. Relapse to smoking. Clin Psychol Rev 2006;26:196-215.
5. Walsh RA, Paul CL, Tzelepis F, Stojanovski E. Quit smoking behaviours and intentions and hard-core smoking in New South Wales. Health Promot J Austr 2006;17:54-60.
6. Warner KE, Burns DM. Hardening and the hard core smoker: concepts, evidence and implications. Nicotine Tob Res 2003;5:37-48.
7. Australian Institute of Health and Welfare (AIHW). Australia's Health 2006. AIHW Cat. No. AUS 73. Canberra, 2006.
8. Baker A, Ivers RG, Bowman J, etal. Where there's smoke, there's fire: high prevalence of smoking among some sub-populations and recommendations for intervention. Drug Alcohol Rev 2006;25:85-96.
9. Degenhardt L, Hall W. The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-Being. Nicotine Tob Res 2001;3:225-34.
10. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness. A population-based prevalence study. JAMA 2000;284:2606-10.
11. Williams JM, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav 2004;29:1067-83.
12. Clemmey P, Brooner R, Chutuape MA, Kidorf M, Stitzer M. Smoking habits and attitudes in a methadone maintenance treatment population. Drug Alcohol Depend 1997;44:123-32.
13. Stein MD, Anderson BJ, Niaura R. Smoking cessation patterns in methadone-maintained smokers. Nicotine Tob Res 2007;9:421-8.
14. Ross J, Teesson M, Darke S, etal. The characteristics of heroin users entering treatment: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Rev 2005;24:411-18.
15. Hser YI, McCarthy WJ, Anglin MD. Tobacco use as a distal predictor of mortality among long term narcotics addicts. Prev Med 1994;23:61-9.
16. Hurt RD, Offord KP, Croghan IT, etal. Mortality following inpatient addictions treatment. JAMA 1996;275:1097-103.
17. Doolan DM, Froelicher ES. Efficacy of smoking cessation intervention among special populations. Nurs Res 2006;55:S29-S37.
18. Clarke JG, Stein MD, McGarry KA, Gogineni A. Interest in smoking cessation among injection drug users. Am J Addict 2001;10:159-66.
19. Frosch DL, Shoptaw S, Jarvik ME, Rawson RA, Ling W. Interest in smoking cessation among methadone maintained outpatients. J Addict Dis 1998;17:9-19.
20. Nahvi S, Richter KP, Li X, Modali L, Arnsten J. Cigarette smoking and interest in quitting in methadone maintenance patients. Addict Behav 2006;31:2127-34.
21. Richter KP, Gibson CA, Ahluwalia JS, Schmelzle KH. Tobacco use and quit attempts among methadone maintenance clients. Am J Public Health 2001;91:296-9.
22. Richter KP, McCool RM, Okuyemu KS, Mayo MS, Ahluwalia JS. Patients' views on smoking cessation and tobacco harm reduction during drug treatment. Nicotine Tob Res 2002;4(Suppl. 2):S175-S182.
23. Ritter A, Chalmers J. Polygon: the many sides to the Australian opioid pharmacotherapy maintenance system. ANCD Research Paper 18. Canberra: Australian National Council on Drugs, 2009.
24. Tate JC, Schmidt JM. A proposed revision of the Fagerstrom Tolerance Questionnaire. Addict Behav 1993;18:135-43.
25. Dawe S, Loxton NJ, Hides L, Kavanagh DJ, Mattick RP. Review of diagnostic screening instruments for alcohol and other drug use and other psychiatric disorders, 2nd edn. Canberra: Commonwealth Department of Health and Ageing, 2002.
26. Di Clemente CC, Prochaska JO, Fairhurst S, Velicer WF, Rossi JS, Velasquez M. The process of smoking cessation: an analysis of precontemplation, contemplation and contemplation/action. J Consult Clin Psychol 1991;59:295-304.
27. Velicer WF, Fava JL, Prochaska JO, Abrams DB, Emmons KM, Pierce J. Distribution of smokers by stage in three representative samples. Prev Med 1995;24:401-11.
28. Feng Y, Niu T, Xing H, etal. A common haplotype of the nicotine acetylcholine receptor a4 subunit gene is associated with vulnerbaility to nicotine addiction in men. Am J Hum Genet 2004;75:112-21.
29. Hendricks PS, Prochaska JJ, Humfleet GL, Hall S. Evaluating the validities of different DSM-IV-based conceptual constructs of tobacco dependence. Addiction 2008;103:1215-23.
30. Australian Bureau of Statistics (ABS). Basic Community Profile; 2006 Census Community Profile Series. ABS Cat. No. 2001.0 Commonwealth of Australia, 2007.
31. Graham-Clarke P, Nathan S, Stoker L, Bauman A, Wise M. Health Promotion Survey 1994. Best practice for reducing the prevalence of smoking in the areas of NSW: NSW Health. State Health Publication No.: (HP) 96-0006, 1996.
32. Trotter L, Letcher T. Quit evaluation studies No. 10. Melbourne: Victorian Smoking and Health Program, 2000.
33. Richter KP, McCool RM, Catley D, Hall M, Ahluwahlia JS. Dual pharmacotherapy and motivational interviewing for tobacco dependence among drug treatment patients. J Addict Dis 2005;24:79-90.
34. Schmitz JM, Rhoades H, Grabowski J. Contingent reinforcement for reduced carbon monoxide levels in methadone maintenance patients. Addict Behav 1995;20:171-9.
35. Shoptaw S, Jarvik ME, Ling W, Rawson RA. Contingency management for tobacco smoking in methadone-maintained opiate addicts. Addict Behav 1996;21:409-12.
36. Shoptaw S, Rotheram-Fuller E, Yang X, etal. Smoking cessation in methadone maintenance. Addiction 2002;97:1317-28.
37. Stein MD, Weinstock MC, Herman DS, Anderson BJ, Anthony JL, Niaura R. A smoking cessation intervention for the methadone-maintained. Addiction 2006;101:599-607.
38. West R, Sohal T. 'Catastrophic' pathways to smoking cessation: findings from a national survey. BMJ 2006;332:458-60.
39. Chapman S, Borland R, Scollo M, Bronwon RC, Dominello A, Woodward S. The impact of smoke-free workplaces on declining cigarette consumption in Australia and the United States. Am J Public Health 1999;89:1018-23.
40. Havassy BE, Hall SM, Wasserman DA. Social support and relapse: commonalities among alcoholics, opiate users and cigarette smokers. Addict Behav 1991;16:235-46.
41. Siahpush M, Borland R, Scollo M. Factors associated with smoking cessation in a national sample of Australians. Nicotine Tob Res 2003;5:597-602.
42. Amos A, Wiltshire S, Bostock Y, Haw S, McNeill A. 'You can't go without a fag...you need it for your hash'-a qualitative exploration of smoking, cannabis and young people. Addiction 2004;99:77-81.
43. Highet G. The role of cannabis in supporting young peoples' cigarettes smoking: a qualitative exploration. Health Educ Res 2004;19:635-43.
44. Darke S, Swift W, Hall W. Prevalence, severity and correlates of psychological morbidity among methadone maintenance clients. Addiction 1994;89:211-17.
45. Peles E, Schreiber S, Naumovsky Y, Adelson M. Depression in methadone maintenance treatment patients: rate and risk factors. J Affect Disord 2007;99:213-20.
46. Kalman D, Morissette SB, George TP. Comorbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 2005;14:106-23.
47. Meyer TJ, Lin MM, Brown LS. Nicotine dependence and depression among methadone maintenance patients. J Natl Med Assoc 1996;88:800-4.
48. Garrison GD, Dugan SE. Varenicline: a first-line treatment option for smoking cessation. Clin Ther 2009;31:463-91.
49. McCool RM, Richter KP, Choi WS. Benefits of and barriers to providing smoking treatment in methadone clinics: findings from a national study. Am J Addict 2005;14:358-66.
50. Olsen Y, Alford DP, Horton JJ, Saitz R. Addressing smoking cessation in methadone programs. J Addict Dis 2005;24:33-48.
51. Richter KP, Choi WS, McCool RM, Harris KJ, Ahluwalia JS. Smoking cessation services in U.S. methadone maintenance facilities. Psychiatr Serv 2004;55:1258-64.
52. Bowman JA, Walsh RA. Smoking intervention within alcohol and other drug treatment services: a selective review with suggestions for practical management. Drug Alcohol Rev 2003;22:77-82.
53. Walsh RA, Bowman JA, Tzelepis F, Lecathelinais C. Smoking cessation interventions in Australian drug treatment agencies: a national survey of attitudes and practices. Drug Alcohol Rev 2005;24:235-44.
54. Gates S, Williams MA, Withers E, Williamson E, Mt-Isa S, Lamb SE. Does a monetary incentive improve the response to a postal questionnaire in a randomised controlled trial? The MINT incentive study. Trials 2009;10:doi:10.1186/1745-6215-10-44.